<?xml version="1.0" encoding="UTF-8"?>

<document id="DDI-MedLine.d28"> 
   <sentence id="DDI-MedLine.d28.s0" text="New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.
" new_text="New@@oral@@therapies@@for@@type@@2@@diabetes@@mellitus@@:@@The@@glitazones@@or@@insulin@@sensitizers@@.@@"> 
      <entity id="DDI-MedLine.d28.s0.e0" charOffset="53-62" type="group" text="glitazones" position="10"/> 
   </sentence>  
   <sentence id="DDI-MedLine.d28.s1" text="Type 2 diabetes mellitus is a growing problem not only in the United States but also across the world. " new_text="Type@@2@@diabetes@@mellitus@@is@@a@@growing@@problem@@not@@only@@in@@the@@United@@States@@but@@also@@across@@the@@world@@.@@"/>  
   <sentence id="DDI-MedLine.d28.s2" text="There is now strong evidence that intensive control of blood glucose can significantly reduce and retard the microvascular complications of retinopathy, nephropathy, and neuropathy. " new_text="There@@is@@now@@strong@@evidence@@that@@intensive@@control@@of@@blood@@glucose@@can@@significantly@@reduce@@and@@retard@@the@@microvascular@@complications@@of@@retinopathy@@,@@nephropathy@@,@@and@@neuropathy@@.@@"/>  
   <sentence id="DDI-MedLine.d28.s3" text="Ultimately however, up to 80% of type 2 diabetics die from macrovascular cardiovascular disease. " new_text="Ultimately@@however@@,@@up@@to@@80%@@of@@type@@2@@diabetics@@die@@from@@macrovascular@@cardiovascular@@disease@@.@@"/>  
   <sentence id="DDI-MedLine.d28.s4" text="This increased incidence of atherosclerotic disease is intricately associated with insulin resistance, which is a major pathophysiologic abnormality in type 2 diabetes. " new_text="This@@increased@@incidence@@of@@atherosclerotic@@disease@@is@@intricately@@associated@@with@@insulin@@resistance@@,@@which@@is@@a@@major@@pathophysiologic@@abnormality@@in@@type@@2@@diabetes@@.@@"/>  
   <sentence id="DDI-MedLine.d28.s5" text="There is strong evidence that insulin resistance is involved in the development of not only hyperglycemia, but also dyslipidemia, hypertension, hypercoagulation, vasculopathy, and ultimately atherosclerotic cardiovascular disease. " new_text="There@@is@@strong@@evidence@@that@@insulin@@resistance@@is@@involved@@in@@the@@development@@of@@not@@only@@hyperglycemia@@,@@but@@also@@dyslipidemia@@,@@hypertension@@,@@hypercoagulation@@,@@vasculopathy@@,@@and@@ultimately@@atherosclerotic@@cardiovascular@@disease@@.@@"/>  
   <sentence id="DDI-MedLine.d28.s6" text="This cluster of metabolic abnormalities has been termed the insulin resistance or cardiovascular dysmetabolic syndrome. " new_text="This@@cluster@@of@@metabolic@@abnormalities@@has@@been@@termed@@the@@insulin@@resistance@@or@@cardiovascular@@dysmetabolic@@syndrome@@.@@"/>  
   <sentence id="DDI-MedLine.d28.s7" text="The thiazolidinediones (rosiglitazone and pioglitazone), a new class of oral antidiabetic agents, are &quot;insulin sensitizers&quot; " new_text="The@@thiazolidinediones@@(@@rosiglitazone@@and@@pioglitazone@@)@@,@@a@@new@@class@@of@@oral@@antidiabetic agents@@,@@are@@&quot;insulin@@sensitizers&quot;@@"> 
      <entity id="DDI-MedLine.d28.s7.e0" charOffset="4-21" type="group" text="thiazolidinediones" position="1"/>  
      <entity id="DDI-MedLine.d28.s7.e1" charOffset="24-36" type="drug" text="rosiglitazone" position="3"/>  
      <entity id="DDI-MedLine.d28.s7.e2" charOffset="42-53" type="drug" text="pioglitazone" position="5"/>  
      <entity id="DDI-MedLine.d28.s7.e3" charOffset="77-95" type="group" text="antidiabetic agents" position="13"/>  
      <pair id="DDI-MedLine.d28.s7.p0" e1="DDI-MedLine.d28.s7.e0" e2="DDI-MedLine.d28.s7.e1" ddi="false" flags="True" e1_name="thiazolidinediones" e2_name="rosiglitazone" e1_pos="1" e2_pos="3" path="1@@3@@">thiazolidinediones@@@@amod@@rosiglitazone</pair>  
      <pair id="DDI-MedLine.d28.s7.p1" e1="DDI-MedLine.d28.s7.e0" e2="DDI-MedLine.d28.s7.e2" ddi="false" flags="True" e1_name="thiazolidinediones" e2_name="pioglitazone" e1_pos="1" e2_pos="5" path="1@@3@@6@@5@@">thiazolidinediones@@@@amod@@rosiglitazone@@conj_and@@)@@nn@@pioglitazone</pair>  
      <pair id="DDI-MedLine.d28.s7.p2" e1="DDI-MedLine.d28.s7.e0" e2="DDI-MedLine.d28.s7.e3" ddi="false" flags="True" e1_name="thiazolidinediones" e2_name="antidiabetic agents" e1_pos="1" e2_pos="13" path="1@@3@@10@@13@@">thiazolidinediones@@@@amod@@rosiglitazone@@appos@@class@@prep_of@@antidiabetic agents</pair>  
      <pair id="DDI-MedLine.d28.s7.p3" e1="DDI-MedLine.d28.s7.e1" e2="DDI-MedLine.d28.s7.e2" ddi="false" flags="True" e1_name="rosiglitazone" e2_name="pioglitazone" e1_pos="3" e2_pos="5" path="3@@6@@5@@">rosiglitazone@@@@conj_and@@)@@nn@@pioglitazone</pair>  
      <pair id="DDI-MedLine.d28.s7.p4" e1="DDI-MedLine.d28.s7.e1" e2="DDI-MedLine.d28.s7.e3" ddi="false" flags="True" e1_name="rosiglitazone" e2_name="antidiabetic agents" e1_pos="3" e2_pos="13" path="3@@10@@13@@">rosiglitazone@@@@appos@@class@@prep_of@@antidiabetic agents</pair>  
      <pair id="DDI-MedLine.d28.s7.p5" e1="DDI-MedLine.d28.s7.e2" e2="DDI-MedLine.d28.s7.e3" ddi="false" flags="True" e1_name="pioglitazone" e2_name="antidiabetic agents" e1_pos="5" e2_pos="13" path="5@@6@@3@@10@@13@@">pioglitazone@@@@nn@@)@@conj_and@@rosiglitazone@@appos@@class@@prep_of@@antidiabetic agents</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d28.s8" text="and exert direct effects on the mechanisms of insulin resistance. " new_text="and@@exert@@direct@@effects@@on@@the@@mechanisms@@of@@insulin@@resistance@@.@@"/>  
   <sentence id="DDI-MedLine.d28.s9" text="These effects not only improve insulin sensitivity and glycemic control with reduced insulin requirements, but also have potentially favorable effects on other components of the cardiovascular dysmetabolic syndrome. " new_text="These@@effects@@not@@only@@improve@@insulin@@sensitivity@@and@@glycemic@@control@@with@@reduced@@insulin@@requirements@@,@@but@@also@@have@@potentially@@favorable@@effects@@on@@other@@components@@of@@the@@cardiovascular@@dysmetabolic@@syndrome@@.@@"/>  
   <sentence id="DDI-MedLine.d28.s10" text="Long-term studies are needed to determine whether the insulin-sensitizing effects of the glitazones can prevent or delay premature atherosclerotic cardiovascular disease, morbidity, and death." new_text="Long-term@@studies@@are@@needed@@to@@determine@@whether@@the@@insulin-sensitizing@@effects@@of@@the@@glitazones@@can@@prevent@@or@@delay@@premature@@atherosclerotic@@cardiovascular@@disease@@,@@morbidity@@,@@and@@death@@.@@"> 
      <entity id="DDI-MedLine.d28.s10.e0" charOffset="89-98" type="group" text="glitazones" position="12"/> 
   </sentence> 
</document>
